ENAapplication/xmlftp.sra.ebi.ac.uk/vol1/fastq/SRR133/011/SRR13344611/SRR13344611_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR133/013/SRR13344613/SRR13344613_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR133/014/SRR13344614/SRR13344614_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR133/013/SRR13344613/SRR13344613_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR133/012/SRR13344612/SRR13344612_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR133/012/SRR13344612/SRR13344612_2.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR133/011/SRR13344611/SRR13344611_1.fastq.gzftp.sra.ebi.ac.uk/vol1/fastq/SRR133/014/SRR13344614/SRR13344614_1.fastq.gzprimaryOK200Genomics517, Respiratory Medicine, The University of Tokyohttps://www.ebi.ac.uk/ena/browser/view/PRJNA689310Mus musculusWe have previously demonstrated that TNF-α, a proinflammatory cytokine, enhances TGF-β-mediated EMT in A549 human lung cancer cells. RNA-sequencing analysis on CMT64 cells following TGF-β and/or TNF-α treatment revealed a subset of genes possibly regulated by TGF-β and/or TNF-α. Overall design: CMT64 cells were stimulated with 5 ng/ml of TGF-β and/or 10 ng/ml of TNF-α, and RNA-sequencing was performed ugsing Illumina HiSeq.ENAdif, tnfa, dTAF[[II]]230, TAF[[II]]250, d230, TNF-alpha, Transcriptome, determination, Transcriptome Profile, xtnf, TNF, Expression Profiles, TAF200, TNFA, Gene Expression Profile, ggr, Gene, l(3)84Ab, dTAFII250, Profiles, BG:DS00004.13, TAFII-250, TAF250/230, EfW1, Cell, dTAF230, dt1, Gene Expression, dmTAF[[II]]230, tnfsf2, TNF-a, TAFII250, dmTAF1, Taf230, p230, Expression Signatures, Regg1, Gene Expression Signatures, chemical analysis, tnf-alpha, TAF[[II]]250/230, TFIID, Gene Expression Signature, Expression Profile, xtnf-alpha, Transcriptome Profiles, TAF250, Taf[[II]]250, Taf200, dTAF[[II]]250, TAF[[II]]230, TFIID TAF250, cel, regg1, cell, Profile, RATTNF, CG12919, Taf1p, TAF[II]250, TNFalpha, BcDNA:RH51659, CG17603, TAF[[II]], DmelCG12919, Ect1, Signatures, DIF, dTAF250, DmelCG17603, darth, Taf250, Expression Signature, Gene Expression Profiles, SR3-5, Transcriptomes, TNFSF2, Egr, Tnfa, assay, Signature, TAF, TAF230, Tnfsf1a., TAF1dif, tnfa, dTAF[[II]]230, TAF[[II]]250, d230, TNF-alpha, Transcriptome, determination, Transcriptome Profile, xtnf, TNF, Expression Profiles, TAF200, TNFA, Gene Expression Profile, ggr, Gene, l(3)84Ab, dTAFII250, Profiles, BG:DS00004.13, TAFII-250, TAF250/230, EfW1, Cell, dTAF230, dt1, Gene Expression, dmTAF[[II]]230, tnfsf2, TNF-a, TAFII250, dmTAF1, Taf230, p230, Expression Signatures, Regg1, Gene Expression Signatures, chemical analysis, tnf-alpha, TAF[[II]]250/230, TFIID, Gene Expression Signature, Expression Profile, xtnf-alpha, Transcriptome Profiles, TAF250, Taf[[II]]250, Taf200, dTAF[[II]]250, TAF[[II]]230, TFIID TAF250, cel, regg1, cell, Profile, RATTNF, CG12919, Taf1p, TAF[II]250, TNFalpha, BcDNA:RH51659, CG17603, TAF[[II]], DmelCG12919, Ect1, Signatures, DIF, dTAF250, DmelCG17603, darth, Taf250, Expression Signature, Gene Expression Profiles, SR3-5, Transcriptomes, TNFSF2, Egr, Tnfa, assay, Signature, TAF, TAF230, Tnfsf1a., TAF10.00.00.00.00.0falseTranscriptome analysis of CMT64 cells following TGF-β and/or TNF-α treatment.Transcriptome analysis of CMT64 cells following TGF-β and/or TNF-α treatment.2022-07-192021-12-19PRJNA689310GSE1641603478977910090